Natural Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.73M Buy
5,609
+111
+2% +$113K 1.48% 15
2026
Q1
$5.06M Buy
5,498
+84
+2% +$85.2K 1.25% 16
2025
Q4
$5.82M Buy
5,414
+39
+0.7% +$37.3K 1.45% 15
2025
Q3
$4.1M Sell
5,375
-163
-3% -$121K 1.02% 21
2025
Q2
$4.32M Buy
5,538
+139
+3% +$108K 1.12% 18
2025
Q1
$4.46M Sell
5,399
-23
-0.4% -$19.1K 1.26% 15
2024
Q4
$4.18M Buy
+5,422
New +$4.49M 1.16% 16

Other funds holding LLY

Natural Investments's LLY Position: Q2 2026 in Review

Natural Investments increased its Eli Lilly (LLY) stake by 2% in Q2 2026, buying an estimated $113K and bringing the position to 5,609 shares worth $6.73M. The position accounts for 1.48% of the portfolio, ranked #15.

Natural Investments first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 3,039 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Natural Investments held 5,609 shares of Eli Lilly worth $6.73M as of Q2 2026.
  • Natural Investments bought 111 Eli Lilly shares in Q2 2026, an estimated $113K.
  • Eli Lilly made up 1.48% of Natural Investments's portfolio in Q2 2026, its #15 holding.
  • Natural Investments first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 3,039 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Natural Investments's 13F filing for Q2 2026, filed 31 Jul 2026.